Category Archives: Uncategorized

24 Sep

Alexion Hits Study Goals, Could Expand Blockbuster Drug to CNS

Alexion Pharmaceuticals’ flagship drug has made a strong case it can treat yet another rare disease, and the company is

24 Sep

Research Headlines – Blue e-infrastructure to inform blue growth policy

[Source: Research & Innovation] Without a clear view of marine resources and environments, efforts to derive sustainable growth from the

24 Sep

UN Proposals to Weaken IP Will Not Benefit Patients

Next week the 73rd session of the United Nations General Assembly (UNGA) will convene in New York City. Among the

22 Sep

Equillium Plans IPO to Fund Clinical Trials for Transplant Drug

Equillium, a biotech startup developing treatments for immune system disorders-including an immune response that affects some transplant recipients-is preparing for

21 Sep

GMOs: Responding to the Issue of Food Waste and Loss

Food waste and food loss is a hot topic right now and rightly so.  The United Nations has set a

21 Sep

SR One’s Brian Gallagher Jumps to Abingworth for Partner Post

Brian Gallagher is joining London-based Abingworth as a partner based in the life sciences investment firm’s Boston office. Gallagher comes

21 Sep

‘Cultural and creative cities for all’- Knowledge Exchange Platform workshop – 11 October 2018, Brussels, Belgium

[Source: Research & Innovation] Are you curious to know how integrating immigrants can contribute to the revitalisation of historic centres?

20 Sep

Elanco IPO Raises $1.5B as the Animal Health Biz Spins Off from Lilly

Elanco is now a standalone company after raising $1.5 billion in its stock market debut. Greenfield, IN-based Elanco (NYSE: ELAN)

20 Sep

2018-2020 Mobility for Growth

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-MG-2018-2019-2020Pillar: Societal ChallengesOpening Date: Deadline: Wed, 31 Jan 2018 17:00:00 (Brussels local time)Modification Date: Thu, 20 Sep